Cognitive Outcomes in Stable Renal Transplant Patients Switched fromTacrolimus to Envarsus XR™
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess cognitive outcome and quality of life in stable renal
transplant patients treated with twice daily tacrolimus at baseline and after switching to
Envarsus XL. The study is designed to see if switching patients from Tacrolimus to Envarsus
treatment improves cognitive function.